Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (119)	2/19/2000 12:30:00 PM
From: Alfred W. Post	Read Replies (1) \| Respond to of 362

You must know that Novartis is a Swiss firm with worldwide insterests. London is more interntional than Basel. I bought into Titan Pharm. when I read that Novartis is cooperating with them. My reasoning is simple: I guess that if a large firm like Novatis teems up with little Titan, than they must know that Titan is promissing. And I was right. When I bought Titan it sold for $3.50 and look at it now. I jusst sent Norartis an e-mail and told them that they should do as well as TTP (While Novartis increased earnings by 11% the performance of its stock is lousy) I also told themtey couldmerge with Titan, why not!!!. Rumers have it that they are trying to list their shares in NY. your Fred Post from Switzerland